Concepedia

Neng-Yang Shih

NS

3

Publications

90

Citations

3

H-Index

2002

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Neng-Yang Shih is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2002–2011

3

Publications

3

I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles

G. Anilkumar, Charles A. Lesburg, Oleg Selyutin et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 49 citations

, , +5

Identification of a novel, orally bioavailable histamine H3 receptor antagonist based on the 4-benzyl-(1H-imidazol-4-yl) template

Robert Aslanian, Mwangi wa Mutahi, Neng-Yang Shih et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 27 citations · Full text

Synthesis and structure–activity relationships of oxime neurokinin antagonists: discovery of potent arylamides

Neng-Yang Shih, Margaret M. Albanese, John C. Anthes et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 14 citations · Full text

, , +9

Rows per page

1–3 of 3